BRÈVE

sur MONOGRAM ORTHOPAEDICS INC (NASDAQ:MGRM)

Monogram Orthopaedics Joins NVIDIA Inception Program to Advance Orthopedic Robotics

Monogram Orthopaedics Inc. (NASDAQ:MGRM), a pioneering medical technology firm specializing in reconstructive joint procedures and surgical robotics, has announced its induction into the NVIDIA Inception program. This strategic move provides Monogram with unprecedented access to cutting-edge technology and resources to enhance the development and commercialization of its innovative mBôs robotic surgical system.

The NVIDIA Inception program is designed to catapult startups into the forefront of their industries by providing technical support, go-to-market strategies, and opportunities for networking with investors and industry experts. For Monogram, participation in this program means access to NVIDIA's best technical tools, resources, and collaborative opportunities to accelerate the path to market for its orthopedic solutions, including robotic surgical equipment, orthopedic implants, and other surgical tools.

Monogram's CEO, Ben Sexson, emphasized the immense potential this collaboration holds for revolutionizing orthopedic surgical practices. With NVIDIA's support, Monogram aims to expedite the commercial launch of the mBôs system, streamline next-gen product development, and work towards FDA clearance with efficiency and economic prudence. The Inception program, renowned for supporting AI startups, now counts Monogram among its select members, underscoring the company's innovative approach to integrating 3D printing and robotics for optimized orthopedic surgery outcomes.

R. P.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de MONOGRAM ORTHOPAEDICS INC